S
Scientia Vascular
Health Tech & Medtech · West Valley City, United States · Founded 2007
Innovative neurovascular devices utilizing advanced micromachining for precise clot removal and smoother navigation MoreLess
Scientia Vascular, founded in 2007 and headquartered in Salt Lake City, specializes in developing advanced neurovascular devices. The company leverages cutting-edge micromachining technology to create high-precision guidewires and catheters, primarily serving healthcare providers in the neurovascular treatment space. Their flagship products, such as the Colossus Guidewire and the 38 Aspiration Catheter, are designed to minimize the ledge effect and enhance navigation through the vasculature, thereby improving clot removal outcomes. Scientia Vascular operates in the medical technology market, focusing on innovation and quality to maintain a competitive edge. The company generates revenue through the sale of its FDA-cleared medical devices, targeting hospitals and specialized medical centers. Key milestones include the FDA clearance of their first product in 2014 and subsequent advancements in microfabrication technology. The company benefits from its strategic location in Salt Lake City, which offers access to a rich talent pool and a burgeoning medical technology sector. Keywords: neurovascular, micromachining, guidewires, catheters, clot removal, FDA-cleared, medical devices, innovation, healthcare, Salt Lake City.
Company overview
Scientia Vascular company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2007
- Headquarters
- West Valley City, United States
- Employees
- 166
- Open positions
- 18
- Dealroom signal
- 73.5
Valuation & funding
Scientia Vascular funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Mar 2026 | $550M | $550M | Medtronic | ↗ |
| LATE VCOther financing | Sep 2024 | $14M | $56M | Piper Sandler | ↗ |
| DEBTDebt | Jan 2022 | $25M | — | Armentum Partners | ↗ |
| GROWTH EQUITY VCOther financing | May 2021 | $50M | — | Vivo Capital | — |
Growth signals
Scientia Vascular website traffic
Latest recorded traffic for Scientia Vascular is 3.8K monthly website visits, up 46.2% over the last three months. Scientia Vascular's team declined 0.6% over the past year.
Hiring
Open positions at Scientia Vascular
Current openings linked to this company in Dealroom.
Comparisons
Scientia Vascular compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Scientia Vascular's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Scientia Vascular has talent and traffic
team presence
In the news
Latest news about Scientia Vascular
Recent press, funding announcements, and product moves mentioning Scientia Vascular — open to read from the original sources.
Market sentiment
What the market is saying about Scientia Vascular
An AI-synthesized read of the highest-engagement posts about Scientia Vascular on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Scientia Vascular’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.











